BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 23643349)

  • 21. Administration of an acylated GLP-1 and GIP preparation provides added beneficial glucose-lowering and insulinotropic actions over single incretins in mice with Type 2 diabetes and obesity.
    Gault VA; Kerr BD; Harriott P; Flatt PR
    Clin Sci (Lond); 2011 Aug; 121(3):107-17. PubMed ID: 21332446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired incretin secretion and pancreatic dysfunction with older age and diabetes.
    Geloneze B; de Oliveira Mda S; Vasques AC; Novaes FS; Pareja JC; Tambascia MA
    Metabolism; 2014 Jul; 63(7):922-9. PubMed ID: 24854384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incretin-based therapy of type 2 diabetes mellitus.
    Knop FK; Vilsbøll T; Holst JJ
    Curr Protein Pept Sci; 2009 Feb; 10(1):46-55. PubMed ID: 19275672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice.
    Hansotia T; Drucker DJ
    Regul Pept; 2005 Jun; 128(2):125-34. PubMed ID: 15780432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastric inhibitory polypeptide analogues: do they have a therapeutic role in diabetes mellitus similar to that of glucagon-like Peptide-1?
    Holst JJ
    BioDrugs; 2002; 16(3):175-81. PubMed ID: 12102645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of incretin on diabetes mellitus.
    Sanusi H
    Acta Med Indones; 2009 Oct; 41(4):205-12. PubMed ID: 20737753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The incretin effect in cats: comparison between oral glucose, lipids, and amino acids.
    Gilor C; Graves TK; Gilor S; Ridge TK; Weng HY; Dossin O
    Domest Anim Endocrinol; 2011 May; 40(4):205-12. PubMed ID: 21397435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Roux-en-Y gastric bypass versus calorie restriction: support for surgery per se as the direct contributor to altered responses of insulin and incretins to a mixed meal.
    Berggren J; Lindqvist A; Hedenbro J; Groop L; Wierup N
    Surg Obes Relat Dis; 2017 Feb; 13(2):234-242. PubMed ID: 27894746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel extrapancreatic effects of incretin.
    Yamada Y; Tsukiyama K; Sato T; Shimizu T; Fujita H; Narita T
    J Diabetes Investig; 2016 Apr; 7 Suppl 1(Suppl 1):76-9. PubMed ID: 27186360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of variations in duodenal glucose load on glycaemic, insulin, and incretin responses in type 2 diabetes.
    Ma J; Pilichiewicz AN; Feinle-Bisset C; Wishart JM; Jones KL; Horowitz M; Rayner CK
    Diabet Med; 2012 May; 29(5):604-8. PubMed ID: 22004512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enteroinsular signaling: perspectives on the role of the gastrointestinal hormones glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide in normal and abnormal glucose metabolism.
    Vahl T; D'Alessio D
    Curr Opin Clin Nutr Metab Care; 2003 Jul; 6(4):461-8. PubMed ID: 12806222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes.
    Nauck MA; El-Ouaghlidi A; Gabrys B; Hücking K; Holst JJ; Deacon CF; Gallwitz B; Schmidt WE; Meier JJ
    Regul Pept; 2004 Nov; 122(3):209-17. PubMed ID: 15491793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on incretin hormones.
    Phillips LK; Prins JB
    Ann N Y Acad Sci; 2011 Dec; 1243():E55-74. PubMed ID: 22545749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New therapeutic approach in patients with type 2 diabetes based on glucagon-like peptide 1 (GLP-1) and gastric inhibitory peptide (GIP)].
    Kluz J; Adamiec R
    Postepy Hig Med Dosw (Online); 2006; 60():15-23. PubMed ID: 16407790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathophysiology of type 2 diabetes and the role of incretin hormones and beta-cell dysfunction.
    Fujioka K
    JAAPA; 2007 Dec; Suppl():3-8. PubMed ID: 18217245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bile Modulates Secretion of Incretins and Insulin: A Study of Human Extrahepatic Cholestasis.
    Mezza T; Moffa S; Ferraro PM; Quero G; Capece U; Carfì A; Cefalo CMA; Cinti F; Sorice GP; Impronta F; Mari A; Pontecorvi A; Alfieri S; Holst JJ; Giaccari A
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2685-2694. PubMed ID: 30874733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GIP: no longer the neglected incretin twin?
    Kulkarni RN
    Sci Transl Med; 2010 Sep; 2(49):49ps47. PubMed ID: 20844284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential.
    Østoft SH
    Dan Med J; 2015 Sep; 62(9):. PubMed ID: 26324089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overview of incretin hormones.
    Efendic S; Portwood N
    Horm Metab Res; 2004; 36(11-12):742-6. PubMed ID: 15655702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small intestinal glucose exposure determines the magnitude of the incretin effect in health and type 2 diabetes.
    Marathe CS; Rayner CK; Bound M; Checklin H; Standfield S; Wishart J; Lange K; Jones KL; Horowitz M
    Diabetes; 2014 Aug; 63(8):2668-75. PubMed ID: 24696447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.